{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:53:39Z","timestamp":1791366819123,"version":"4.3.1"},"reference-count":62,"publisher":"Bentham Science Publishers Ltd.","issue":"26","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>The receptor for pyroglutamylated RF amide peptide (QRFPR)\nis a G protein-coupled receptor that plays a role in various physiological and pathological\nprocesses. However, a gap remains in our understanding of QRFPR's pan-cancer\nproperties.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This study performs an extensive pan-cancer analysis of QRFPR utilizing\nlarge-scale genomic datasets, including The Cancer Genome Atlas (TCGA). We evaluated\nQRFPR expression levels in multiple malignancies and examined their correlations\nwith clinical outcomes. Additionally, we investigated associations between QRFPR expression\nand immune cell infiltration using bioinformatics tools.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Our results reveal significant alterations in QRFPR expression across several\ncancer types, particularly breast, colorectal, and prostate cancers. Elevated levels of\nQRFPR are linked to poor prognosis in certain malignancies, such as uterine corpus endometrial\ncarcinoma (UCEC) and mesothelioma (MESO), and correlate with increased\ninfiltration of immune cells, especially T cells and macrophages. Pathway enrichment\nanalyses suggest that QRFPR may impact critical signaling pathways associated with\ncell growth, apoptosis, and immune regulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>The observed variations in QRFPR expression across cancer types suggest\nits diverse roles in tumor biology. Its association with unfavorable clinical outcomes in\nspecific cancers, as well as its link to immune cell infiltration, highlights its multifaceted\nimpact on tumor progression and microenvironment modulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our findings underscore the potential of QRFPR as a prognostic biomarker\nand therapeutic target in cancer biology. Further investigations into its functional mechanisms\ncould pave the way for precision medicine approaches in oncology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0109298673386201250806154911","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T04:49:31Z","timestamp":1759294171000},"page":"5465-5491","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive Pan-cancer analysis of Pyroglutamylated RFamide Peptide Receptor: Its Potential Biological Functions and Associations with Prognosis and Immunity"],"prefix":"10.2174","volume":"33","author":[{"given":"Quanxin","family":"Huang","sequence":"first","affiliation":[{"name":"School of Information and Management, Guangxi Medical University, Nanning, 530021, China"},{"name":"Life SciencesInstitute, Guangxi Medical University, Nanning, 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyuan","family":"Qiu","sequence":"additional","affiliation":[{"name":"Life SciencesInstitute, Guangxi Medical University, Nanning, 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Lu","sequence":"additional","affiliation":[{"name":"Collaborative Innovation Centre ofRegenerative Medicine and Medical BioResource Development and Application Co-constructed by theProvince and Ministry, Guangxi Medical University, Nanning, 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mocan","family":"Qiu","sequence":"additional","affiliation":[{"name":"Life SciencesInstitute, Guangxi Medical University, Nanning, 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daizheng","family":"Huang","sequence":"additional","affiliation":[{"name":"Life SciencesInstitute, Guangxi Medical University, Nanning, 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"Siegel R.L.","year":"2024","unstructured":"Siegel R.L.; Giaquinto A.N.; Jemal A.; Cancer statistics, 2024. CA Cancer J Clin  2024,74(1),12-49","journal-title":"CA Cancer J Clin"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1021\/acs.molpharmaceut.4c00856","volume":"22","author":"Kedar P.","year":"2025","unstructured":"Kedar P.; Saraf A.; Maheshwari R.; Sharma M.; Advances in dendritic systems and dendronized nanoparticles: Paradigm shifts in cancer targeted therapy and diagnostics. Mol Pharm  2025,22(1),28-57","journal-title":"Mol Pharm"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1509342","DOI":"10.3389\/fgene.2024.1509342","volume":"15","author":"Li G.","year":"2024","unstructured":"Li G.; Wang Y.; Wang W.; Lv G.; Li X.; Wang J.; Liu X.; Yuan D.; Deng S.; You D.; BIRC5 as a prognostic and diagnostic biomarker in pan-cancer: An integrated analysis of expression, immune subtypes, and functional networks. Front Genet  2024,15,1509342","journal-title":"Front Genet"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"104599","DOI":"10.1016\/j.critrevonc.2024.104599","volume":"206","author":"Zhang Y.","year":"2025","unstructured":"Zhang Y.; Huang Z.; Lu W.; Liu Z.; Alternative polyadenylation in cancer: Molecular mechanisms and clinical application. Crit Rev Oncol Hematol  2025,206,104599","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286-287","author":"Sonkin D.","year":"2024","unstructured":"Sonkin D.; Thomas A.; Teicher B.A.; Cancer treatments: Past, present, and future. Cancer Genet  2024,286-287,18-24","journal-title":"Cancer Genet"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/ot9.0000000000000039","volume":"10","author":"Joshi R.","year":"2024","unstructured":"Joshi R.; Telang B.; Soni G.; Khalife A.; Overview of perspectives on cancer, newer therapies, and future directions. Oncol Transl Med  2024,10,105-109","journal-title":"Oncol Transl Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13045-024-01647-1","volume":"17","author":"Chen Y.","year":"2024","unstructured":"Chen Y.; Dai S.; Cheng C.; Chen L.; Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, clinical efficacy, and future perspectives. J Hematol Oncol  2024,17(1),130","journal-title":"J Hematol Oncol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"27652","DOI":"10.1074\/jbc.M302945200","volume":"278","author":"Jiang Y.","year":"2003","unstructured":"Jiang Y.; Luo L.; Gustafson E.L.; Yadav D.; Laverty M.; Murgolo N.; Vassileva G.; Zeng M.; Laz T.M.; Behan J.; Qiu P.; Wang L.; Wang S.; Bayne M.; Greene J.; Monsma F.; Zhang F.L.; Identification and characterization of a novel RF-amide peptide ligand for orphan G-protein-coupled receptor SP9155. J Biol Chem  2003,278(30),27652-27657","journal-title":"J Biol Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"46387","DOI":"10.1074\/jbc.M305270200","volume":"278","author":"Fukusumi S.","year":"2003","unstructured":"Fukusumi S.; Yoshida H.; Fujii R.; Maruyama M.; Komatsu H.; Habata Y.; Shintani Y.; Hinuma S.; Fujino M.; A new peptidic ligand and its receptor regulating adrenal function in rats. J Biol Chem  2003,278(47),46387-46395","journal-title":"J Biol Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"100557","DOI":"10.1016\/j.xgen.2024.100557","volume":"4","author":"Arora C.","year":"2024","unstructured":"Arora C.; Matic M.; Bisceglia L.; Di Chiaro P.; De Oliveira Rosa N.; Carli F.; Clubb L.; Nemati Fard L.A.; Kargas G.; Diaferia G.R.; Vukotic R.; Licata L.; Wu G.; Natoli G.; Gutkind J.S.; Raimondi F.; The landscape of cancer-rewired GPCR signaling axes. Cell Genomics  2024,4(5),100557","journal-title":"Cell Genomics"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1113\/expphysiol.2004.027169","volume":"89","author":"Dockray G.J.","year":"2004","unstructured":"Dockray G.J.; The expanding family of -RFamide peptides and their effects on feeding behaviour. Exp Physiol  2004,89(3),229-235","journal-title":"Exp Physiol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1038\/s41467-024-49030-5","volume":"15","author":"Iwama A.","year":"2024","unstructured":"Iwama A.; Kise R.; Akasaka H.; Sano F.K.; Oshima H.S.; Inoue A.; Shihoya W.; Nureki O.; Structure and dynamics of the pyroglutamylated RF-amide peptide QRFP receptor GPR103. Nat Commun  2024,15(1),4769","journal-title":"Nat Commun"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"e0275604","DOI":"10.1371\/journal.pone.0275604","volume":"17","author":"Cook C.","year":"2022","unstructured":"Cook C.; Nunn N.; Worth A.A.; Bechtold D.A.; Suter T.; Gackeheimer S.; Foltz L.; Emmerson P.J.; Statnick M.A.; Luckman S.M.; The hypothalamic RFamide, QRFP, increases feeding and locomotor activity: The role of Gpr103 and orexin receptors. PLoS One  2022,17(10),e0275604","journal-title":"PLoS One"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3892\/or.2018.6893","volume":"41","author":"Kawan MA.","year":"2019","unstructured":"Kawan MA.; Kyrou I.; Ramanjaneya M.; Williams K.; Jeyaneethi J.; Randeva HS.; Karteris E.; Involvement of the glutamine RF-amide peptide and its cognate receptor GPR103 in prostate cancer. Oncol Rep  2019,41(2),1140-1150","journal-title":"Oncol Rep"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ejca.2012.05.028","volume":"49","author":"Alonzeau J.","year":"2013","unstructured":"Alonzeau J.; Alexandre D.; Jeandel L.; Courel M.; Hautot C.; El Yamani FZ.; Gobet F.; Leprince J.; Magoul R.; Amarti A.; Pfister C.; Yon L.; Anouar Y.; Chartrel N.; The neuropeptide 26RFa is expressed in human prostate cancer and stimulates the neuroendocrine differentiation and the migration of androgeno-independent prostate cancer cells. Eur J Cancer  2013,49(2),511-519","journal-title":"Eur J Cancer"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000538629","volume":"115","author":"Dev\u00e8re M.","year":"2024","unstructured":"Dev\u00e8re M.; Takhlidjt S.; Pr\u00e9vost G.; Chartrel N.; Leprince J.; Picot M.; The 26RFa (QRFP)\/GPR103 neuropeptidergic system: A key regulator of energy and glucose metabolism. Neuroendocrinology  2024,115(2),111-127","journal-title":"Neuroendocrinology"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"146325","DOI":"10.1016\/j.gene.2022.146325","volume":"822","author":"Liu H.","year":"2022","unstructured":"Liu H.; Weng J.; A comprehensive bioinformatic analysis of cyclin-dependent kinase 2 (CDK2) in glioma. Gene  2022,822,146325","journal-title":"Gene"},{"key":"ref=18","first-page":"2140","volume":"15","author":"Liu H.","year":"2023","unstructured":"Liu H.; Tang T.; A bioinformatic study of IGFBPs in glioma regarding their diagnostic, prognostic, and therapeutic prediction value. Am J Transl Res  2023,15(3),2140-2155","journal-title":"Am J Transl Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"167844","DOI":"10.1016\/j.bbadis.2025.167844","volume":"1871","author":"Liu H.","year":"2025","unstructured":"Liu H.; Hamaia S.W.; Dobson L.; Weng J.; Hern\u00e1ndez F.L.; Beaudoin C.A.; Salvage S.C.; Huang C.L.H.; Machesky L.M.; Jackson A.P.; The voltage-gated sodium channel \u03b23 subunit modulates C6 glioma cell motility independently of channel activity. Biochim Biophys Acta Mol Basis Dis  2025,1871(6),167844","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"167693","DOI":"10.1016\/j.bbadis.2025.167693","volume":"1871","author":"Nojima Y.","year":"2025","unstructured":"Nojima Y.; Yao R.; Suzuki T.; Single-cell RNA sequencing and machine learning provide candidate drugs against drug-tolerant persister cells in colorectal cancer. Biochim Biophys Acta Mol Basis Dis  2025,1871(3),167693","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"19142","DOI":"10.1038\/s41598-024-70184-1","volume":"14","author":"Liu H.","year":"2024","unstructured":"Liu H.; Dong A.; Rasteh A.M.; Wang P.; Weng J.; Identification of the novel exhausted T cell CD8 markers in breast cancer. Sci Rep  2024,14(1),19142","journal-title":"Sci Rep"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3233\/CBM-220143","volume":"35","author":"Liu H.","year":"2022","unstructured":"Liu H.; Li Y.; Potential roles of cornichon family AMPA receptor auxiliary protein 4 (CNIH4) in head and neck squamous cell carcinoma. Cancer Biomark  2022,35(4),439-450","journal-title":"Cancer Biomark"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3233\/CBM-210340","volume":"34","author":"Li Y.","year":"2022","unstructured":"Li Y.; Liu H.; Clinical powers of aminoacyl tRNA synthetase complex interacting multifunctional protein 1 (AIMP1) for head-neck squamous cell carcinoma. Cancer Biomark  2022,34(3),359-374","journal-title":"Cancer Biomark"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"102042","DOI":"10.1016\/j.genrep.2024.102042","volume":"37","author":"Liu H.","year":"2024","unstructured":"Liu H.; Guo Z.; Wang P.; Genetic expression in cancer research: Challenges and complexity. Gene Rep  2024,37,102042","journal-title":"Gene Rep"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.7150\/jca.100922","volume":"16","author":"Liu H.","year":"2025","unstructured":"Liu H.; Li Y.; Karsidag M.; Tu T.; Wang P.; Technical and biological biases in bulk transcriptomic data mining for cancer research. J Cancer  2025,16(1),34-43","journal-title":"J Cancer"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"119046","DOI":"10.1016\/j.bbamcr.2021.119046","volume":"1868","author":"Ma Q.","year":"2021","unstructured":"Ma Q.; Cao Z.; Li H.; Wang W.; Tian Y.; Yan L.; Liao Y.; Chen X.; Chen Y.; Shi Y.; Tang S.; Zhou N.; Two naturally occurring mutations of human GPR103 define distinct G protein selection bias. Biochim Biophys Acta Mol Cell Res  2021,1868(7),119046","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.3390\/molecules26144312","volume":"26","author":"Lefranc B.","year":"2021","unstructured":"Lefranc B.; Alim K.; Neveu C.; Le Marec O.; Dubessy C.; Boutin J.A.; Chuquet J.; Vaudry D.; Pr\u00e9vost G.; Picot M.; Vaudry H.; Chartrel N.; Leprince J.; Point-substitution of phenylalanine residues of 26RFa neuropeptide: A structure-activity relationship study. Molecules  2021,26(14),4312","journal-title":"Molecules"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"T119","DOI":"10.1530\/JME-13-0207","volume":"52","author":"Ukena K.","year":"2014","unstructured":"Ukena K.; Osugi T.; Leprince J.; Vaudry H.; Tsutsui K.; Molecular evolution of GPCRS: 26Rfa\/GPR103. J Mol Endocrinol  2014,52(3),T119-T131","journal-title":"J Mol Endocrinol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"de Visser K.E.","year":"2023","unstructured":"de Visser K.E.; Joyce J.A.; The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell  2023,41(3),374-403","journal-title":"Cancer Cell"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cancergen.2021.12.001","volume":"260-261","author":"El Azzouzi M.","year":"2022","unstructured":"El Azzouzi M.; El Ahanidi H.; Hafidi Alaoui C.; Chaoui I.; Benbacer L.; Tetou M.; Hassan I.; Bensaid M.; Oukabli M.; Ameur A.; Al Bouzidi A.; El Mzibri M.; Attaleb M.; Evaluation of DNA methylation in promoter regions of hTERT, TWIST1, VIM and NID2 genes in Moroccan bladder cancer patients. Cancer Genet  2022,260-261,41-45","journal-title":"Cancer Genet"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1051\/medsci\/2024180","volume":"40","author":"Gorse M.","year":"2024","unstructured":"Gorse M.; Bianchi C.; Proudhon C.; Epigenetics and cancer: The role of DNA methylation. Med Sci  2024,40(12),925-934","journal-title":"Med Sci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"6070","DOI":"10.21037\/tcr-24-1029","volume":"13","author":"Wan M.","year":"2024","unstructured":"Wan M.; Meng H.; Li H.; Potential role of TWIST1 and its methylation in bladder urothelial carcinoma. Transl Cancer Res  2024,13(11),6070-6086","journal-title":"Transl Cancer Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.arcmed.2022.11.003","volume":"53","author":"Recillas-Targa F.","year":"2022","unstructured":"Recillas-Targa F.; Cancer epigenetics: An overview. Arch Med Res  2022,53(8),732-740","journal-title":"Arch Med Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1093\/jnci\/djae334","volume":"117","author":"Lolas-Hamameh S.","year":"2025","unstructured":"Lolas-Hamameh S.; Lieberman S.; Sarahneh A.; Walsh T.; Lee MK.; Gulsuner S.; Rabie G.; Beeri R.; Aburayyan A.; Mandell JB.; Fridman H.; Lazer-Derbeko G.; Klopstock T.; Freireich O.; Lahad A.; King MC; Levy-Lahad E.; Kanaan MN.; TP53 missense allele predisposing to high risk of breast cancer but not pediatric cancers. J Natl Cancer Inst  2025,117(5),1069-1073","journal-title":"J Natl Cancer Inst"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s12032-024-02318-4","volume":"41","author":"Xiong K.","year":"2024","unstructured":"Xiong K.; Fang Y.; Qiu B.; Chen C.; Huang N.; Liang F.; Huang C.; Lu T.; Zheng L.; Zhao J.; Zhu B.; Investigation of cellular communication and signaling pathways in tumor microenvironment for high TP53-expressing osteosarcoma cells through single-cell RNA sequencing. Med Oncol  2024,41(5),93","journal-title":"Med Oncol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.pbiomolbio.2024.12.003","volume":"195","author":"Weng J.","year":"2025","unstructured":"Weng J.; Shan Y.; Chang Q.; Cao C.; Liu X.; Research progress on N6-Methyladenosine modification in angiogenesis, vasculogenic mimicry, and therapeutic implications in breast cancer. Prog Biophys Mol Biol  2025,195,57-70","journal-title":"Prog Biophys Mol Biol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/s41420-024-02266-y","volume":"10","author":"Zhao Y.","year":"2024","unstructured":"Zhao Y.; Li J.; Dian M.; Bie Y.; Peng Z.; Zhou Y.; Zhou B.; Hao W.; Wang X.; Role of N6-methyladenosine methylation in nasopharyngeal carcinoma: current insights and future prospective. Cell Death Discov  2024,10(1),490","journal-title":"Cell Death Discov"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1517604","DOI":"10.3389\/fimmu.2024.1517604","volume":"15","author":"Wang X.","year":"2024","unstructured":"Wang X.; Ma X.; Chen S.; Fan M.; Jin C.; Chen Y.; Wang S.; Wang Z.; Meng F.; Zhang C.; Yang L.; Harnessing m1A modification: A new frontier in cancer immunotherapy. Front Immunol  2024,15,1517604","journal-title":"Front Immunol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1475979","DOI":"10.3389\/fonc.2024.1475979","volume":"14","author":"Zhao D.","year":"2024","unstructured":"Zhao D.; Yu X.; Huang H.; Zou S.; Zhu P.; Lin Y.; Song M.; Fu F.; Yang H.; Association of the SNPs in CCL2 and CXCL12 genes with the susceptibility to breast cancer: A case-control study in China. Front Oncol  2024,14,1475979","journal-title":"Front Oncol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"155909","DOI":"10.1016\/j.cyto.2022.155909","volume":"155","author":"Masih M.","year":"2022","unstructured":"Masih M.; Agarwal S.; Kaur R.; Gautam P.K.; Role of chemokines in breast cancer. Cytokine  2022,155,155909","journal-title":"Cytokine"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"849720","DOI":"10.1155\/2014\/849720","volume":"2014","author":"Palacios-Arreola MI.","year":"2014","unstructured":"Palacios-Arreola MI.; Nava-Castro KE.; Castro JI.; Garc\u00eda-Zepeda E.; Carrero JC.; Morales-Montor J.; The role of chemokines in breast cancer pathology and its possible use as therapeutic targets. J Immunol Res  2014,2014,849720","journal-title":"J Immunol Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri.2017.49","volume":"17","author":"Nagarsheth N.","year":"2017","unstructured":"Nagarsheth N.; Wicha M.S.; Zou W.; Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol  2017,17(9),559-572","journal-title":"Nat Rev Immunol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s43657-023-00118-w","volume":"3","author":"Yan L.","year":"2023","unstructured":"Yan L.; Li W.; Chen F.; Wang J.; Chen J.; Chen Y.; Ye W.; Inflammation as a mediator of microbiome dysbiosis-associated dna methylation changes in gastric premalignant lesions. Phenomics  2023,3(5),496-501","journal-title":"Phenomics"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ccell.2023.12.010","volume":"42","author":"Hoekstra M.E.","year":"2024","unstructured":"Hoekstra M.E.; Slagter M.; Urbanus J.; Toebes M.; Slingerland N.; de Rink I.; Kluin R.J.C.; Nieuwland M.; Kerkhoven R.; Wessels L.F.A.; Schumacher T.N.; Distinct spatiotemporal dynamics of CD8 T cell-derived cytokines in the tumor microenvironment. Cancer Cell  2024,42(1),157-167.e9","journal-title":"Cancer Cell"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2307695","DOI":"10.1002\/advs.202307695","volume":"11","author":"Schneider C.","year":"2024","unstructured":"Schneider C.; Hilbert J.; Genevaux F.; H\u00f6fer S.; Krau\u00df L.; Schicktanz F.; Contreras C.T.; Jansari S.; Papargyriou A.; Richter T.; Alfayomy A.M.; Falcomat\u00e0 C.; Schneeweis C.; Orben F.; \u00d6llinger R.; Wegwitz F.; Boshnakovska A.; Rehling P.; M\u00fcller D.; Str\u00f6bel P.; Ellenrieder V.; Conradi L.; Hessmann E.; Ghadimi M.; Grade M.; Wirth M.; Steiger K.; Rad R.; Kuster B.; Sippl W.; Reichert M.; Saur D.; Schneider G.; A novel AMPK inhibitor sensitizes pancreatic cancer cells to ferroptosis induction. Adv Sci  2024,11(31),2307695","journal-title":"Adv Sci"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"17588359231217976","DOI":"10.1177\/17588359231217976","volume":"15","author":"Williams N.O.","year":"2023","unstructured":"Williams N.O.; Quiroga D.; Johnson C.; Brufsky A.; Chambers M.; Bhattacharya S.; Patterson M.; Sardesai S.D.; Stover D.; Lustberg M.; Noonan A.M.; Cherian M.; Bystry D.M.; Hill K.L.; Chen M.; Phelps M.A.; Grever M.; Stephens J.A.; Ramaswamy B.; Carson W.E.; Wesolowski R.; Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancer. Ther Adv Med Oncol  2023,15,17588359231217976","journal-title":"Ther Adv Med Oncol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1158\/1078-0432.CCR-14-0979","volume":"21","author":"Shapiro G.I.","year":"2015","unstructured":"Shapiro G.I.; Kwak E.; Dezube B.J.; Yule M.; Ayrton J.; Lyons J.; Mahadevan D.; First-in-human phase I dose escalation study of a second-generation non-ansamycin HSP90 inhibitor, AT13387, in patients with advanced solid tumors. Clin Cancer Res  2015,21(1),87-97","journal-title":"Clin Cancer Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s40257-024-00910-y","volume":"26","author":"Reschke R.","year":"2025","unstructured":"Reschke R.; Enk AH.; Hassel JC.; Prognostic biomarkers in evolving melanoma immunotherapy. Am J Clin Dermatol  2025,26(2),213-223","journal-title":"Am J Clin Dermatol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cancergen.2024.09.001","volume":"288-289","author":"Jahangiri L.","year":"2024","unstructured":"Jahangiri L.; Updates on liquid biopsies in neuroblastoma for treatment response, relapse and recurrence assessment. Cancer Genet  2024,288-289,32-39","journal-title":"Cancer Genet"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cancergen.2023.12.002","volume":"280-281","author":"Ohyama H.","year":"2024","unstructured":"Ohyama H.; Hirotsu Y.; Amemiya K.; Mikata R.; Amano H.; Hirose S.; Oyama T.; Iimuro Y.; Kojima Y.; Mochizuki H.; Kato N.; Omata M.; Development of a molecular barcode detection system for pancreaticobiliary malignancies and comparison with next-generation sequencing. Cancer Genet  2024,280-281,6-12","journal-title":"Cancer Genet"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergen.2023.12.003","volume":"282-283","author":"Gonzalez T.","year":"2024","unstructured":"Gonzalez T.; Nie Q.; Chaudhary L.N.; Basel D.; Reddi H.V.; Methylation signatures as biomarkers for non-invasive early detection of breast cancer: A systematic review of the literature. Cancer Genet  2024,282-283,1-8","journal-title":"Cancer Genet"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40364-024-00620-x","volume":"12","author":"Liu H.","year":"2024","unstructured":"Liu H.; Weng J.; Huang C.L.H.; Jackson A.P.; Voltage- gated sodium channels in cancers. Biomark Res  2024,12(1),70","journal-title":"Biomark Res"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cancergen.2023.10.001","volume":"278-279","author":"Liu H.","year":"2023","unstructured":"Liu H.; Tang T.; Pan-cancer genetic analysis of disulfidptosis-related gene set. Cancer Genet  2023,278-279,91-103","journal-title":"Cancer Genet"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"952290","DOI":"10.3389\/fonc.2022.952290","volume":"12","author":"Liu H.","year":"2022","unstructured":"Liu H.; Tang T.; Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set. Front Oncol  2022,12,952290","journal-title":"Front Oncol"},{"key":"ref=55","first-page":"4074","volume":"12","author":"Liu H.","year":"2022","unstructured":"Liu H.; Pan-cancer profiles of the cuproptosis gene set. Am J Cancer Res  2022,12(8),4074-4081","journal-title":"Am J Cancer Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"166941","DOI":"10.1016\/j.bbadis.2023.166941","volume":"1870","author":"Kang Z.R.","year":"2024","unstructured":"Kang Z.R.; Jiang S.; Han J.X.; Gao Y.; Xie Y.; Chen J.; Liu Q.; Yu J.; Zhao X.; Hong J.; Chen H.; Chen Y.X.; Chen H.; Fang J.Y.; Deficiency of BCAT2-mediated branched-chain amino acid catabolism promotes colorectal cancer development. Biochim Biophys Acta Mol Basis Dis  2024,1870(2),166941","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"167250","DOI":"10.1016\/j.bbadis.2024.167250","volume":"1870","author":"Lee S.J.","year":"2024","unstructured":"Lee S.J.; Jeon S.H.; Cho S.; Kim C.M.; Yoo J.K.; Oh S.H.; Kim J.H.; Yang Y.D.; Kim J.K.; hsa-miR-CHA2, a novel microRNA, exhibits anticancer effects by suppressing cyclin E1 in human non-small cell lung cancer cells. Biochim Biophys Acta Mol Basis Dis  2024,1870(6),167250","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.trecan.2024.05.001","volume":"10","author":"Singh M.","year":"2024","unstructured":"Singh M.; Morris V.K.; Bandey I.N.; Hong D.S.; Kopetz S.; Advancements in combining targeted therapy and immunotherapy for colorectal cancer. Trends Cancer  2024,10(7),598-609","journal-title":"Trends Cancer"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"108613","DOI":"10.1016\/j.pharmthera.2024.108613","volume":"256","author":"Splendiani E.","year":"2024","unstructured":"Splendiani E.; Besharat Z.M.; Covre A.; Maio M.; Di Giacomo A.M.; Ferretti E.; Immunotherapy in melanoma: Can we predict response to treatment with circulating biomarkers? Pharmacol Ther  2024,256,108613","journal-title":"Pharmacol Ther"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"108667","DOI":"10.1016\/j.pharmthera.2024.108667","volume":"259","author":"Ramapriyan R.","year":"2024","unstructured":"Ramapriyan R.; Vykunta V.S.; Vandecandelaere G.; Richardson L.G.K.; Sun J.; Curry W.T.; Choi B.D.; Altered cancer metabolism and implications for next-generation CAR T-cell therapies. Pharmacol Ther  2024,259,108667","journal-title":"Pharmacol Ther"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"166881","DOI":"10.1016\/j.bbadis.2023.166881","volume":"1870","author":"Yu X.","year":"2024","unstructured":"Yu X.; Zhai X.; Wu J.; Feng Q.; Hu C.; Zhu L.; Zhou Q.; Evolving perspectives regarding the role of the PD-1\/PD-L1 pathway in gastric cancer immunotherapy. Biochim Biophys Acta Mol Basis Dis  2024,1870(1),166881","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"166917","DOI":"10.1016\/j.bbadis.2023.166917","volume":"1870","author":"Niu L.","year":"2024","unstructured":"Niu L.; Wang Q.; Feng F.; Yang W.; Xie Z.; Zheng G.; Zhou W.; Duan L.; Du K.; Li Y.; Tian Y.; Chen J.; Xie Q.; Fan A.; Dan H.; Liu J.; Fan D.; Hong L.; Zhang J.; Zheng J.; Small extracellular vesicles-mediated cellular interactions between tumor cells and tumor-associated macrophages: Implication for immunotherapy. Biochim Biophys Acta Mol Basis Dis  2024,1870(2),166917","journal-title":"Biochim Biophys Acta Mol Basis Dis"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673386201250806154911","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/245649\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673386201250806154911","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:23:12Z","timestamp":1791364992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/245649\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":62,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673386201250806154911","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-03-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}